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Background: Vitamin D deficiency rickets is common in China. Genetic factors may play an important role in the
susceptibility to rickets. Our study aimed to identify the relationship between three vitamin D-related genes (group
specific component [GC], cytochrome P450, family 2, subfamily R, polypeptide 1 (CYP2R1), and 7-dehydrocholesterol
reductase/nicotinamide-adenine dinucleotide synthetase 1 (DHCR7/NADSYN1) and rickets in Han Chinese children
from northeastern China.
Methods: A total of 506 Han children from northeastern China were enrolled in the current study. Twelve SNPs in
three candidate genes were genotyped using the SNaPshot assay. Linear regression was used to examine the effect
of 12 single-nucleotide polymorphisms (SNPs) on the risk of rickets.
Results: In our case–control cohort, six alleles of the 12 SNPs conferred a significantly increased risk of rickets in GC
(rs4588 C, P = 0.003, OR: 0.583, 95% CI: 0.412-0.836; rs222020 C, P = 0.009, OR: 1.526, 95% CI: 1.117-2.0985; rs2282679
A, P = 0.010, OR: 0.636, 95% CI: 0.449-0.900; and rs2298849 C, P = 0.001, OR: 1.709, 95% CI: 1.250-2.338) and in CYP2R1
(rs10741657 G, P = 0.019, OR: 1.467, 95% CI: 1.070-2.011; and rs2060793 G, P = 0.023, OR: 0.689, 95% CI: 0.502-0.944).
The results remained significant after adjustment for sex and body mass index. We further analyzed the effect of
genotypes under three different genetic models. After using Bonferroni’s method for multiple corrections, rs4588,
rs2282679, and rs2298849 of the GC gene were significantly associated with rickets under the dominant (P =0.003
for rs4588, P =0.024 for rs2282679, and P =0.005 for rs2298849) and additive models (P = 0.006 for rs4588, P = 0.024
for rs2282679, and P = 0.005 for rs2298849). Haplotype analysis showed that the CAT haplotype of the GC gene
(P = 0.005) and the GAA haplotype of the CYP2R1 gene (P = 0.026) were associated with susceptibility to rickets.
Conclusions: This case–control study confirmed the strong effect of GC and CYP2R1 loci on rickets in Han children
from northeastern China.
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Vitamin D deficiency rickets is related to limited expos-
ure to sunlight, poor nutrition and/or decreased dietary
intake of vitamin D. Although people are encouraged to
obtain adequate exposure to sunlight and fortified milk
with vitamin D supplements, this disease remains com-
mon and has the potential to produce an epidemic out-
break in children in developing countries, such as China* Correspondence: renlihong1@163.com
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reproduction in any medium, provided the or[1,2]. The prevalence of rickets among rural Chinese
children was reported to be 26.7% [3].
Recent studies have indicated that genetic factors may
play an important role in the susceptibility to rickets. How-
ever, only a few studies have examined the association be-
tween the vitamin D receptor (VDR) and rickets [4-7]. The
most frequently studied loci include ApaI, TaqI, BsmI, and
FokI, based on small sample sizes, with inconsistent re-
sults. Giampiero et al. (2008) examined BsmI and FokI in
98 Middle Eastern rachitic subjects and found that VDR
genotypes may predispose the population to rickets by an
increasing frequency of the F allele. Kaneko et al. (2007)Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Clinical characteristics of the participants




Age (years) 1.77 ± 1.07 7.17 ± 3.89△
BMI (kg/m2) 18.43 ± 4.21 18.14 ± 3.37
Calcium (mmol/L) 2.33 ± 0.16 2.42 ± 0.13△
Phosphate (mmol/L) 1.69 ± 0.24 1.67 ± 0.19
Alkaline phosphatase (IU/L) 207.33 ± 54.64 231.72 ± 69.52△
Serum 25(OH)D (ng/ml)a 11.82 ± 6.95 23.58 ± 8.20△
Regular vitamin D useb
Yes 19 193△
No 86 208
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of rickets in 80 children aged 7–10 years in Mongolia with
a history of rickets, without any possible results. Several
studies [8-13] also examined the association between VDR
and rickets in Chinese subjects.
The group specific component (GC), cytochrome P450,
family 2, subfamily R, polypeptide 1 (CYP2R1), and 7-
dehydrocholesterol reductase/nicotinamide-adenine dinuc-
leotide synthetase 1 (DHCR7/NADSYN1) genes are all
involved in vitamin D metabolism and/or transportation
[14-16]. These three genes are associated with 25(OH)D
concentrations [17-20]. The effect of the genes on the de-
velopment of rickets remains unclear.
This study aimed to investigate the association be-
tween GC, CYP2R1, and DHCR7/NADSYN1 and rickets
in northeastern Han Chinese children.aSerum collected from November to April, 2010.
bIntake of 400 IU/d.
△Significant P values are indicated by a triangle (△P < 0.05).Methods
The study subjects consisted of 506 northeastern Han
Chinese children. Samples were collected from Harbin, a
city in northeastern China. All participants were perman-
ent residents and without consanguinity in three genera-
tions. Children were divided into two groups. One group
was recruited from the outpatient clinic of the Second Af-
filiated Hospital, Harbin Medical University, and subjects
showed obvious clinical symptoms and these were radio-
logically confirmed. Diagnosis of rickets was based on at
least one of the following clinical signs: craniotabes, rach-
itic rosary, Harrison’s groove, delayed closure of the an-
terior fontanelle, delayed dentition, muscular hypotonia,
abdomen of a frog, spinal deformation, pigeon chest, en-
larged wrists, and bowed legs.
The other group was the control cohort, which com-
prised of healthy children with no symptoms or signs of
rickets or history of rickets. These children were all in-
volved in a randomized citywide survey of vitamin D sta-
tus. Subjects who had been treated with vitamin D (except
for a prophylactic supplementation dose, 400 IU/d), cal-
cium, or medications known to interfere with calcium-
phosphate metabolism were excluded.
The study protocol was approved by the Ethics Commit-
tee of Harbin Medical University. Written informed con-
sent was obtained from all the parents of participants.Measurement of vitamin D levels
An enzyme-linked immunosorbent assay was conducted
according to the manufacturer’s instructions (R&D Sys-
tems, Minneapolis, MN, USA) to examine plasma 25
(OH)D levels. Other possible factors related to plasma
25(OH)D levels were collected, such as age, sex, height,
weight, measurement data, and habitual vitamin D sup-
plementation (400 IU/d). Information of the participants
is shown in Table 1.Genotyping
The loci selected for this study included GC (rs4588,
rs7041, rs222020, rs2282679, and rs2298849), CYP2R1
(rs10741657, rs10766197, rs12794714, rs1562902, and
rs2060793), and DHCR7/NADSYN1 (rs3829251 and
rs12785878), all of which have been shown to synthesize
and transport vitamin D. These factors are associated
with vitamin D levels.
Genomic DNA was extracted from peripheral blood leu-
kocytes using the QIAamp DNA Blood Kit (Qiagen). Twelve
single-nucleotide polymorphisms (SNPs) were genotyped
using the SNaPshot assay. Primer3 (http://frodo.wi.mit.edu/)
was used to design primers to amplify a different-sized frag-
ment for each SNP within a multiplex. Extension primers,
again differing in length within a multiplex, were chosen
from the sequence immediately up- or down-stream of each
SNP. Primer interactions within the multiplex were evalu-
ated and minimized using the AutoDimer program (http://
www.cstl.nist.gov/biotech/strbase/AutoDimerHomepage/
AutoDimerProgramHomepage.htm). Polymerase chain re-
action (PCR) contained 10–50 ng of DNA, 1 ×HotStarTaq
buffer, 3 mM MgCl2, 300 μM of each dNTP, 0.08 μM
of each primer, and one unit of HotStarTaq polymerase
(Qiagen) in a 20-μl reaction volume. The following touch-
down PCR program was used: denaturation at 95°C for
15 min, followed by 11 cycles of 94°C for 20 sec, annealing
at 65°C for 40 sec (decreasing by 0.5°C per cycle), and ex-
tension at 72°C for 90 sec. This was followed by 24 cycles
of denaturation at 94°C for 20 sec, annealing at 59°C for
30 sec, and extension at 72°C for 90 sec, and a final exten-
sion at 72°C for 5 min. The PCR products were purified
by treatment with Exonuclease I (USB Corporation) and
shrimp alkaline phosphatase (USB Corporation) at 37°C
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tension reaction contained 1 ×ABI Prism SNaPshot Multi-
plex Ready Reaction Mix (Applied Biosystems), 0.5 μM
of each primer, and 1 μl of each PCR product, and was car-
ried out as recommended (Applied Biosystems). The exten-
sion PCR products were purified using 1 unit of shrimp
alkaline phosphatase and then analyzed using an ABI
3130×l Genetic Analyzer. SNP calling was carried out using
GeneMapperTM software v.4.0 (Applied Biosystems). For
quality control, genotyping was performed without the
knowledge of case/control status of the subjects, and a 5%
random sample of cases and controls was genotyped twice
per SNP for all SNPs by different people; the reproducibil-
ity was 100%.Statistical analysis
To examine the effect of the variants on plasma 25(OH)D
levels, linear regression was performed after adjusting
for sex and body mass index (BMI). The analyses were
performed using dominant, additive, and recessive gen-
etic models. Bonferroni’s method was applied to correct
for multiple testing. Haplotype frequencies for different
genes were estimated using the expectation-maximization
method by Haploview 4.0 software. Statistical analyses
were performed using SPSS software (version 17.0; SPSS,
Chicago, IL, USA). Data were analyzed using two-sided P
values. The Hardy-Weinberg equilibrium was evaluated
using Pearson’s χ2 test (Table 2). Statistical power was
assessed using the Genetic Power Calculator [21].Table 2 Association of 12 SNPs with rickets in cases and cont
Gene SNP MAF p for
HWET
A/a
GC rs4588 0.31 0.30 Ca/A
rs7041 0.26 0.29 T/Ga
rs222020 0.34 0.67 T/Ca
rs2282679 0.32 0.22 Aa/C
rs2298849 0.32 0.98 T/Ca
CYP2R1 rs10741657 0.43 0.25 Ga/A
rs10766197 0.45 0.36 Ga/A
rs12794714 0.43 0.36 G/Aa
rs1562902 0.47 0.46 Ta/C
rs2060793 0.27 0.42 Ga/A
DHCR7/NADSYN1 rs3829251 0.28 0.59 G/Aa
rs12785878 0.49 0.13 Ta/G
A/a major allele/minor allele.
arisk allele.
badjusted for sex and BMI.
MAF, minor allele frequency in the study population.
HWE, P values for Hardy–Weinberg Equilibrium test in the study population.
△Significant P values are indicated by a triangle (△P<0.05).Results
Descriptive analysis
In total, 506 individuals were included in this study. The
baseline characteristics of these individuals are shown in
Table 1. A total of 105 patients had rickets according to
the stated criteria and the other 401 individuals were in-
cluded as controls.
Among the rachitic children in the epidemiological
cohort (n = 105), 49% were male. The mean age was
1.77 ± 1.07 years (mean ± SD), the mean BMI was 18.43 ±
4.21, and the mean serum 25(OH)D level was 11.82 ±
6.95 ng/ml.
The control cohort (n = 401) contained significantly
more male subjects (63%, P = 0.011) and had a similar
mean BMI (18.14 ± 3.37, P > 0.05) compared with the
rachitic cohort (18.43 ± 4.21). The mean age in control
subjects was significantly higher than that of the rachitic
subjects (P = 4.521 × 10-38). However, we had already ex-
cluded patients with a history of rickets. Similar to previ-
ous reports, serum 25(OH)D levels were much higher in
the control cohort than in the rachitic cohort (P = 1.335 ×
10-35) [22]. Biochemical data showed that serum calcium
(P = 6.355 × 10-8) and alkaline phosphatase status (P =
0.001) were higher in controls than in rachitic subjects.
Allelic distribution
We selected and genotyped 12 SNPs significantly associ-
ated with 25(OH)D and/or rickets in a recent genome-
wide association study, and these SNPs were genotyped
in 105 rachitic subjects and 401 control Han individualsrols
Allele-specific (unadjusted) Allele-specific (adjusted)
p value OR (95% CI) p valueb OR (95% CI)
0.003△ 0.587 (0.412-0.836) 0.003△ 0.583 (0.409-0.833)
0.252 1.216 (0.867-1.705) 0.167 1.272 (0.901-1.791)
0.009△ 1.526 (1.117-2.085) 0.009△ 1.517 (1.108-2.078)
0.010△ 0.636 (0.449-0.900) 0.010△ 0.631 (0.444-0.895)
0.001△ 1.709 (1.250-2.338) 0.001△ 1.722 (1.256-2.362)
0.019△ 1.467 (1.070-2.011) 0.016△ 1.477 (1.075-2.030)
0.374 0.855 (0.619-1.179) 0.416 0.874 (0.632-1.209)
0.089 1.322 (0.968-1.804) 0.075 1.330 (0.971-1.820)
0.120 1.279 (0.940-1.740) 0.115 1.284 (0.941-1.751)
0.023△ 0.689 (0.502-0.944) 0.019△ 0.684 (0.498-0.940)
0.297 1.204 (0.863-1.680) 0.342 1.176 (0.841-1.645)
1.000 0.993 (0.733-1.345) 0.879 0.977 (0.719-1.326)
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the two groups were in Hardy–Weinberg equilibrium.
The results are shown in Table 2.
In our case–control cohort, six alleles of 12 SNPs
conferred a significantly increased risk of rickets. TheseTable 3 Association of different genotypes with rickets in cas
SNP Genotype p value*
Additive Dominant









rs2282679 CC 0.003△ 0.002
CA
AA 0.180
























p value*, p values were adjusted for sex and BMI.
p value**, adjusted p values were corrected using the Bonferroni, method.
△Significant P values are indicated by a triangle (△P<0.05).included rs4588 C (P = 0.003, odds ratio [OR]: 0.583, 95%
confidence interval [CI]: 0.412–0.836), rs222020 C (P =
0.009, OR: 1.526, 95% CI: 1.117–2.0985), rs2282679 A (P =
0.010, OR: 0.636, 95% CI: 0.449–0.900), and rs2298849 C
(P = 0.001, OR: 1.709, 95% CI: 1.250–2.338) in GC, andes and controls
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Table 4 Frequency distribution of haplotypes and their
association with rickets in cases and controls
Gene Haplotypea Case (%) Control (%) P value
GC ACT 0.469 0.410 0.1205
CAT 0.229 0.329 0.005△
ACG 0.288 0.249 0.2452
CYP2R1 GAA 0.352 0.437 0.0261△
AGG 0.409 0.340 0.06
GGG 0.238 0.213 0.4281
DHCR7/NADSYN1 TG 0.508 0.503 0.9066
GA 0.298 0.258 0.2352
GG 0.187 0.230 0.1867
aLoci of tag SNPs are written 3′ to 5′ and include the following SNPs: rs4588,
rs7041 and rs2282679 in GC, rs12704714, rs10741657 and 2060793 in CYP2R1
and rs3829251 and rs12785878 in DHCR7/NADSYN1.
△Significant P values are indicated by a triangle (△P<0.05).
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2.011) and rs2060793 G (P = 0.023, OR: 0.689, 95% CI:
0.502–0.944) in CYP2R1. The associations of these
SNPs with rickets remained significant after adjustment
for sex and BMI. The closest association was found in
the GC variant rs2298849 (adjusted P = 0.001). Of the
six SNPs associated with rickets in our study, rs4588,
rs2282679, and rs2298849 showed the same trend of as-
sociation as in previous reports of their association with
rickets in Caucasian ethnic groups [20].
Association of different genotypes and rickets
We further analyzed the effect of genotypes under three
different genetic models. After adjusting for the con-
founding variables of sex and BMI, multiple linear re-
gression analysis showed a significant association of all
variants with rickets (Table 3).
As shown in Table 3, five SNPs in the GC gene were sig-
nificantly associated with rickets under three genetic
models. However, after applying Bonferroni’s correction for
multiple testing, only rs4588, rs2282679, and rs2298849
remained significantly associated with rickets under the
dominant (P = 0.003 for rs4588, P = 0.024 for rs2282679,
and P = 0.005 for rs2298849) and additive models (P =
0.006 for rs4588, P = 0.024 for rs2282679, and P = 0.005 for
rs2298849).
For CYP2R1, individuals with rs2060793 of the G al-
lele were found to confer a significantly increased risk
for rickets under the additive and dominant models (P =
0.028 and P = 0.014, respectively). Variants in rs10741657
and rs10766197 showed weak associations with rickets
under the additive model (P = 0.049 and P = 0.011, re-
spectively). However, after correction for multiple testing,
none of the investigated SNP associations remained statis-
tically significant.
Association of haplotypes with rickets
The frequency distribution of the haplotypes and associ-
ations with rickets are shown in Table 4. The CAT
haplotype of the GC gene was significantly associated
with rickets (P = 0.005). For CYP2R1, the GAA haplotype
frequency was significantly higher in the case cohort
than in the control cohort (P = 0.026). No significant dif-
ference was observed in the frequency of the DHCR7
haplotype in cases and controls.
Discussion
In this study, the association of GC, CYP2R1, and
DHCR7/NADSYN1 polymorphisms with vitamin D defi-
cient rickets in Chinese subjects was reported for the
first time. In this population-based sample, we analyzed
the association of 12 loci of three vitamin D-related
genes with rickets in Han children from Northeast
China. These results suggest that GC and CYP2R1variants are important contributors to susceptibility to
rickets in Chinese children.
GC, also known as vitamin D-binding protein (DBP),
and it is a member of the albumin family [23], encodes
DBP synthesized in the liver and transports vitamin D and
its metabolites. Recently, studies investigated the asso-
ciation between GC polymorphisms and 25(OH)D status
[24-28]. Because certain mutations in the GC gene are
known to cause defects in GC function, we hypothesized
that GC polymorphisms can predict susceptibility to de-
veloping rickets. In the present study, the strongest associ-
ation for developing rickets was found to be with a variant
at rs2298849. Further analysis showed variant genotypes
of SNPs in the GC gene. Five polymorphisms were signifi-
cantly associated with rickets under three genetic models
after adjusting for sex and BMI. Even after Bonferroni’s
correction, rs4588, rs2282679, and rs2298849 remained
significant. Moreover, haplotype analysis suggested that
the CAT haplotype of the GC gene was significantly asso-
ciated with a higher risk of rickets. These results indicate
that the GC gene plays an important role in the patho-
genesis of rickets. The possible mechanism may be via
impaired vitamin D transportation, although other possi-
bilities cannot be ruled out.
Studies have shown that rs4588 and rs7041 generate
functionally different proteins. Such differences affect
circulating 25(OH)D concentrations. The rare allele of
rs7041 codes for the aspartic acid residue at amino acid
position 416 of DBP. The rs4588 allele codes for a lysine
residue at position 420, which allows for differentiation of
three major DBP phenotypes. Being rare homozygote for
both rs7041 and rs4588 characterize the glycosylation
pattern of the protein phenotype Gc2-2. This phenotype
has been shown to be associated with low mean serum
DBP protein concentrations, as well as with low mean
serum 25(OH)D concentrations in post-menopausal
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and rs4588 are associated with lower 25(OH)D concentra-
tions, at least in part because of the lowering effect on
DBP concentrations. Whether the variation in DBP con-
centrations stems from production of different proteins or
degradation rates associated with different DBP genotypes
and phenotypes is unclear. Further study is required to
explore the potential regulatory mechanisms [25,26].
CYP2R1 is a member of the CYP2 family encoding
cytochrome P450 proteins. CYP2R1 is an important
vitamin D 25-hydroxylase that hydroxylates vitamin D at
the 25-C position for 25(OH)D synthesis in the liver
[29]. Previous clinical studies on CYP2R1 are limited to
only one case report of a Nigerian man with a history of
rickets with a point mutation in CYP2R1 [30]. In a recent
study by Wjst et al. [31], the CYP2R1 locus was found to
be associated with circulating 25-hydroxyvitamin D con-
centrations, and rs10766197 was significantly associated
with 25(OH)D status in 872 participants of the German
Asthma Family Study. In addition, Ramos-Lopez et al.
[32] found that rs10741657 in CYP2R1 was associated
with the serum status of 25(OH)D in 609 participants
from 203 families with type 1 diabetes. Our study found
significant evidence that the G allele in rs2060793 and
rs10741657 conferred a high risk under genetic models.
In our study, haplotype-based associations showed that
the significance of associations between haplotypes and
rickets is comparable in magnitude with that observed
with individual SNPs. The major risk haplotype GAA
confers a higher risk than that attributed to other haplo-
types in Chinese children. These findings suggest that
genetic variants of the CYP2R1 gene may play an import-
ant role in the development of rickets.
The third gene examined, DHCR7/NADSYN1, encodes
the enzyme 7-dehydrocholesterol (7-DHC) reductase,
which transforms 7-DHC to cholesterol. This process leads
to removal of that substrate from the synthetic pathway of
vitamin D3, a precursor of 25(OH)D. Cooper et al. showed
that the rs12785878 T allele was significantly associated
with lower levels of 25(OH)D in type 1 diabetic patients
[15]. In our study, we found that two variant genotypes of
DHCR7/NADSYN1 (rs3829251 and rs12785878) were as-
sociated with serum 25(OH)D levels. However, our study
found little evidence that DHCR7/NADSYN1 variants were
associated with a genetic risk of rickets. Genetic heterogen-
eity among different continental populations due to dif-
ferent geographical locations and genetic histories may
explain the inconsistency between these studies. Addition-
ally, differences in the level of environmental risk factors in
different populations may alter the effect of susceptibility
to loci on the levels of 25(OH)D and the risk of rickets.
There are a few limitations to this study. One limita-
tion was the small size of samples and lack of a replica-
tion group. Our findings need to be confirmed in largersamples of Han Chinese children from Northeast China.
Considering that the prevalence of rickets is 20%, there
is a frequency of 26% to 49% for risk alleles, and an
additive genetic model is used, we had 66% to 74%
power to detect an OR of 1.50 at the 0.05 level. Another
limitation was the lack of a comprehensive genetic ana-
lysis. Moreover, we did not identify any clinical differ-
ences between patients with or without risk-associated
haplotypes because our study focused on young children.
Further analyses on patients using a larger sample and
people from different ethnicities may be necessary to
clarify the mechanism involved.
Conclusions
In conclusion, our study shows that there are strong ef-
fects of GC and CYP2R1 loci on rickets in Han children
from northeastern China.
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